Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adiponectin Promotes Functional Recovery after Podocyte Ablation
Joseph M. Rutkowski, Zhao V. Wang, Ae Seo Deok Park, et al.
Journal of the American Society of Nephrology (2013) Vol. 24, Iss. 2, pp. 268-282
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Molecular mechanisms of diabetic kidney disease
Kimberly Reidy, Hyun Mi Kang, Thomas H. Hostetter, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 6, pp. 2333-2340
Open Access | Times Cited: 801
Adiponectin Regulation and Function
Han Fang, Robert L. Judd
Comprehensive physiology (2018), pp. 1031-1063
Closed Access | Times Cited: 579
Adiponectin, the past two decades
Zhao V. Wang, Philipp E. Scherer
Journal of Molecular Cell Biology (2016) Vol. 8, Iss. 2, pp. 93-100
Open Access | Times Cited: 529
Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 496
Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog
Maria Edeling, Grace Ragi, Shizheng Huang, et al.
Nature Reviews Nephrology (2016) Vol. 12, Iss. 7, pp. 426-439
Open Access | Times Cited: 359
Metabolic Messengers: adiponectin
Leon G. Straub, Philipp E. Scherer
Nature Metabolism (2019) Vol. 1, Iss. 3, pp. 334-339
Open Access | Times Cited: 271
The next generation of therapeutics for chronic kidney disease
Matthew D. Breyer, Katalin Suszták
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 8, pp. 568-588
Open Access | Times Cited: 252
Adiponectin, driver or passenger on the road to insulin sensitivity?
Risheng Ye, Philipp E. Scherer
Molecular Metabolism (2013) Vol. 2, Iss. 3, pp. 133-141
Open Access | Times Cited: 240
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
William B. Horton, Eugene J. Barrett
Endocrine Reviews (2020) Vol. 42, Iss. 1, pp. 29-55
Open Access | Times Cited: 226
Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
Sheetal Parida, Sumit Siddharth, Dipali Sharma
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2519-2519
Open Access | Times Cited: 209
Kidney disease and obesity: epidemiology, mechanisms and treatment
Niels Olsen Saraiva Câmara, Kunitoshi Iseki, Holly Kramer, et al.
Nature Reviews Nephrology (2017) Vol. 13, Iss. 3, pp. 181-190
Closed Access | Times Cited: 200
Molecular pathways that drive diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 182
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 48
Immunologic and endocrine functions of adipose tissue: implications for kidney disease
Qingzhang Zhu, Philipp E. Scherer
Nature Reviews Nephrology (2017) Vol. 14, Iss. 2, pp. 105-120
Closed Access | Times Cited: 167
Adiponectin in inflammatory and immune-mediated diseases
Giamila Fantuzzi
Cytokine (2013) Vol. 64, Iss. 1, pp. 1-10
Open Access | Times Cited: 163
αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy
Mingjun Shi, Brianna Flores, Nancy Gillings, et al.
Journal of the American Society of Nephrology (2015) Vol. 27, Iss. 8, pp. 2331-2345
Open Access | Times Cited: 155
The many secret lives of adipocytes: implications for diabetes
Philipp E. Scherer
Diabetologia (2018) Vol. 62, Iss. 2, pp. 223-232
Open Access | Times Cited: 139
The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture
Philipp E. Scherer
Diabetes (2016) Vol. 65, Iss. 6, pp. 1452-1461
Open Access | Times Cited: 124
The metabolic syndrome and chronic kidney disease
Xin Zhang, Lilach O. Lerman
Translational research (2016) Vol. 183, pp. 14-25
Open Access | Times Cited: 124
Regulation of glucose and lipid homeostasis by adiponectin: Effects on hepatocytes, pancreatic β cells and adipocytes
Caroline Tao, Angelica J. Sifuentes, William L. Holland
Best Practice & Research Clinical Endocrinology & Metabolism (2013) Vol. 28, Iss. 1, pp. 43-58
Open Access | Times Cited: 117
Obesity, oxidative stress, and fibrosis in chronic kidney disease
Kumar Sharma
Kidney International Supplements (2014) Vol. 4, Iss. 1, pp. 113-117
Open Access | Times Cited: 113
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia
Mary E. Haas, Amy E. Levenson, Xiaowei Sun, et al.
Circulation (2016) Vol. 134, Iss. 1, pp. 61-72
Open Access | Times Cited: 102
Inflammatory Mediators and Renal Fibrosis
Xiao‐Ming Meng
Advances in experimental medicine and biology (2019), pp. 381-406
Closed Access | Times Cited: 96
Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction
S. Li, Qisheng Lin, Xinghua Shao, et al.
Free Radical Biology and Medicine (2019) Vol. 152, pp. 632-649
Open Access | Times Cited: 95
Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
Yaeni Kim, Cheol Whee Park
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1782-1782
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top